Pro - inflammatory cytokines, lymphocyte subsets and intravenous immunoglobulin therapy in guillain - barre syndrome

Abstract

Both cell-mediated immunity and humoral factors are involved in the pathogenesis of Guillain-Barre syndrome (GBS). Intravenous immunoglobulin (IVIG) has been reported to be a practical, effective and safe treatment in childhood GBS, although the mode of action of IVIG remains uncertain. We studied pro-inflammatory cytokines (interleukin-2, interleukin-1